Abeona Therapeutics Inc Warrant
ABEOW
ABEOW was delisted on the 20th of December, 2019.
2 hedge funds and large institutions have $4.42M invested in Abeona Therapeutics Inc Warrant in 2017 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
4% less capital invested
Capital invested by funds: $4.61M → $4.42M (-$187K)
33% less funds holding
Funds holding: 3 → 2 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$2K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
PA
1
Perceptive Advisors
New York
| $3.69M | – | – | – |
|
|
SFM
2
Soros Fund Management
New York
| $733K | – | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| – | -$2K | -800 | Closed |
|
ABEOW Hedge Fund Activity: Q1 2017 in Review
2 of the 4,018 institutional investors tracked by Wall St. Rank reported a position in Abeona Therapeutics Inc Warrant (ABEOW) for Q1 2017, worth a combined $4.42M — down 4.1% from $4.61M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of ABEOW and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was UBS Group, exiting entirely with an estimated $2K sold.
- 2 institutional investors held Abeona Therapeutics Inc Warrant (ABEOW) as of Q1 2017, down from 3 in Q4 2016.
- Funds reported $4.42M of Abeona Therapeutics Inc Warrant stock for Q1 2017, down 4.1% quarter-over-quarter.
- 0 funds opened new Abeona Therapeutics Inc Warrant positions in Q1 2017 and 1 closed out, a net change of -1 holder.
- The largest Abeona Therapeutics Inc Warrant seller in Q1 2017 was UBS Group, an estimated $2K sold.
Based on aggregated 13F filings for Q1 2017.